Characterization of Early Patients Initiating Ofatumumab for Treatment of Multiple Sclerosis.
Clinical trial NCT05576779 · COMPLETED
Trial details
- NCT number
- NCT05576779
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-12-03
- Primary completion
- 2021-12-31
- Enrollment
- 2101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.